Minoryx raises 21.3 mln euros

Minoryx Therapeutics said Sept. 26 that it raised 21.3 million euros ($25 million) in a Series B round led by Fund+. Also participating were SFPI, S.R.I.W. and Sambrinvest, in addition to all Series A investors (Ysios Capital, Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi Ventures, Caixa Capital Risc and HealthEquity). Minoryx is developing drugs for orphan disease.

North AmericaUSBriefs